ID   AK1CL_RAT               Reviewed;         318 AA.
AC   Q6AYQ2;
DT   18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2004, sequence version 1.
DT   02-OCT-2024, entry version 118.
DE   RecName: Full=Aldo-keto reductase family 1 member C21;
DE            EC=1.1.1.-;
DE   AltName: Full=17-alpha-hydroxysteroid dehydrogenase;
DE            Short=17-alpha-HSD;
DE   AltName: Full=3(or 17)-alpha-hydroxysteroid dehydrogenase;
DE            EC=1.1.1.209;
DE   AltName: Full=3-alpha-hydroxysteroid dehydrogenase;
GN   Name=Akr1c21;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: NADP-dependent 17-alpha-hydroxysteroid dehydrogenase that
CC       converts 5-alpha-androstane-3,17-dione into androsterone. Has lower 3-
CC       alpha-hydroxysteroid dehydrogenase activity. Has broad substrate
CC       specificity and acts on various 17-alpha-hydroxysteroids, 17-
CC       ketosteroids, 3-alpha hydroxysteroids and 3-ketosteroids. Reduction of
CC       keto groups is strictly stereoselective. Reduction of 17-ketosteroids
CC       yields only 17-alpha-hydroxysteroids. Likewise, reduction of 3-
CC       ketosteroids yields only 3-alpha-hydroxysteroids (By similarity).
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=androsterone + NADP(+) = 5alpha-androstan-3,17-dione + H(+) +
CC         NADPH; Xref=Rhea:RHEA:20377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15994,
CC         ChEBI:CHEBI:16032, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         EC=1.1.1.209;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=androsterone + NAD(+) = 5alpha-androstan-3,17-dione + H(+) +
CC         NADH; Xref=Rhea:RHEA:20381, ChEBI:CHEBI:15378, ChEBI:CHEBI:15994,
CC         ChEBI:CHEBI:16032, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945;
CC         EC=1.1.1.209;
CC   -!- SUBUNIT: Monomer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the aldo/keto reductase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC078957; AAH78957.1; -; mRNA.
DR   RefSeq; NP_001013075.1; NM_001013057.1.
DR   AlphaFoldDB; Q6AYQ2; -.
DR   SMR; Q6AYQ2; -.
DR   STRING; 10116.ENSRNOP00000063166; -.
DR   iPTMnet; Q6AYQ2; -.
DR   PhosphoSitePlus; Q6AYQ2; -.
DR   jPOST; Q6AYQ2; -.
DR   PaxDb; 10116-ENSRNOP00000045355; -.
DR   GeneID; 291283; -.
DR   KEGG; rno:291283; -.
DR   UCSC; RGD:1311841; rat.
DR   AGR; RGD:1311841; -.
DR   CTD; 1646; -.
DR   RGD; 1311841; Akr1c21.
DR   VEuPathDB; HostDB:ENSRNOG00000029844; -.
DR   eggNOG; KOG1577; Eukaryota.
DR   HOGENOM; CLU_023205_0_0_1; -.
DR   InParanoid; Q6AYQ2; -.
DR   OrthoDB; 890110at2759; -.
DR   PhylomeDB; Q6AYQ2; -.
DR   TreeFam; TF106492; -.
DR   Reactome; R-RNO-193368; Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol.
DR   Reactome; R-RNO-193775; Synthesis of bile acids and bile salts via 24-hydroxycholesterol.
DR   Reactome; R-RNO-193807; Synthesis of bile acids and bile salts via 27-hydroxycholesterol.
DR   Reactome; R-RNO-2162123; Synthesis of Prostaglandins (PG) and Thromboxanes (TX).
DR   Reactome; R-RNO-5365859; RA biosynthesis pathway.
DR   Reactome; R-RNO-975634; Retinoid metabolism and transport.
DR   Reactome; R-RNO-9757110; Prednisone ADME.
DR   PRO; PR:Q6AYQ2; -.
DR   Proteomes; UP000002494; Chromosome 17.
DR   Bgee; ENSRNOG00000029844; Expressed in liver and 4 other cell types or tissues.
DR   ExpressionAtlas; Q6AYQ2; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0072582; F:17-beta-hydroxysteroid dehydrogenase (NADP+) activity; ISO:RGD.
DR   GO; GO:0072555; F:17-beta-ketosteroid reductase (NADPH) activity; ISO:RGD.
DR   GO; GO:0047024; F:5alpha-androstane-3beta,17beta-diol dehydrogenase activity; ISO:RGD.
DR   GO; GO:0004032; F:aldose reductase (NADPH) activity; ISO:RGD.
DR   GO; GO:0047023; F:androsterone dehydrogenase activity; ISO:RGD.
DR   GO; GO:0032052; F:bile acid binding; ISO:RGD.
DR   GO; GO:0031406; F:carboxylic acid binding; ISO:RGD.
DR   GO; GO:0047086; F:ketosteroid monooxygenase activity; ISO:RGD.
DR   GO; GO:1902121; F:lithocholic acid binding; ISO:RGD.
DR   GO; GO:0070401; F:NADP+ binding; ISO:RGD.
DR   GO; GO:0070402; F:NADPH binding; ISO:RGD.
DR   GO; GO:0016655; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; ISO:RGD.
DR   GO; GO:0018636; F:phenanthrene 9,10-monooxygenase activity; ISO:RGD.
DR   GO; GO:0005496; F:steroid binding; ISO:RGD.
DR   GO; GO:0016229; F:steroid dehydrogenase activity; IBA:GO_Central.
DR   GO; GO:0033764; F:steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; ISO:RGD.
DR   GO; GO:0047115; F:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity; ISO:RGD.
DR   GO; GO:0071395; P:cellular response to jasmonic acid stimulus; ISO:RGD.
DR   GO; GO:0071799; P:cellular response to prostaglandin D stimulus; ISO:RGD.
DR   GO; GO:0044597; P:daunorubicin metabolic process; ISO:RGD.
DR   GO; GO:0007586; P:digestion; ISO:RGD.
DR   GO; GO:0044598; P:doxorubicin metabolic process; ISO:RGD.
DR   GO; GO:0030855; P:epithelial cell differentiation; ISO:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0042448; P:progesterone metabolic process; ISO:RGD.
DR   GO; GO:0006693; P:prostaglandin metabolic process; ISO:RGD.
DR   GO; GO:0008202; P:steroid metabolic process; ISO:RGD.
DR   CDD; cd19108; AKR_AKR1C1-35; 1.
DR   Gene3D; 3.20.20.100; NADP-dependent oxidoreductase domain; 1.
DR   InterPro; IPR020471; AKR.
DR   InterPro; IPR044482; AKR1C.
DR   InterPro; IPR018170; Aldo/ket_reductase_CS.
DR   InterPro; IPR023210; NADP_OxRdtase_dom.
DR   InterPro; IPR036812; NADP_OxRdtase_dom_sf.
DR   PANTHER; PTHR11732:SF480; ALDO-KETO REDUCTASE FAMILY 1 MEMBER C21; 1.
DR   PANTHER; PTHR11732; ALDO/KETO REDUCTASE; 1.
DR   Pfam; PF00248; Aldo_ket_red; 1.
DR   PIRSF; PIRSF000097; AKR; 1.
DR   PRINTS; PR00069; ALDKETRDTASE.
DR   SUPFAM; SSF51430; NAD(P)-linked oxidoreductase; 1.
DR   PROSITE; PS00062; ALDOKETO_REDUCTASE_2; 1.
PE   2: Evidence at transcript level;
KW   Cytoplasm; Lipid metabolism; NADP; Oxidoreductase; Reference proteome;
KW   Steroid metabolism.
FT   CHAIN           1..318
FT                   /note="Aldo-keto reductase family 1 member C21"
FT                   /id="PRO_0000326223"
FT   ACT_SITE        55
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250"
FT   BINDING         20..24
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250"
FT   BINDING         31
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         50
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250"
FT   BINDING         117
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         166..167
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250"
FT   BINDING         190
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250"
FT   BINDING         216..224
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250"
FT   BINDING         270..280
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250"
FT   SITE            84
FT                   /note="Lowers pKa of active site Tyr"
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   318 AA;  36135 MW;  53909644919456D1 CRC64;
     MNSKCHCVKL NDGHFIPVLG FGTAMPSELP KSKAKEVTKI AIDAGFHHFD SAFVYNTEDH
     VGEAIREKIA NGTTRREDIF YTSKLWCTSL HPELVRSSLE CSLKKLQLDY VDLYLIHFPM
     ALKPGDENFP VDEHGKLLFD TVDLCATWEA MEKCKDAGLA KSIGVSNFNR RQLEKILNKP
     GLKYKPVCNQ VECHLYLNQM KLLDFCKTNG IILVAYGVLG TQRYNGWVDQ NSPVLLNEPV
     LSSMAKKYNQ TPALIALRHQ LQRGIVVLNT SLKEERIKEN MKLSPEDMKV LDDLNRNLRY
     IAGGIFEGHP NFPFLDEY
//
